Medical Research Council

A study commissioned by three of the UK’s leading scientific institutions has demonstrated substantial financial and social benefits from investment in medical research.

The UK Medical Research Council is about to begin a survey of scientists it funds, with the aim of demonstrating the value of the research.

Is medical research worth the money? The UK Medical Research Council has commissioned to find out the answer.

In the highest value deal yet seen for a preclinical pipeline, GlaxoSmithKline plc swooped on Domantis Ltd, paying £230 million cash for the six-year-old UK Medical Research Council spin out.